Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

RTTNews | Před 970 dny
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.

EGFR inhibitors are critical therapeutic agents for the treatment of non-small cell lung cancer (NSCLC), pancreatic cancer, colorectal cancer, squamous-cell carcinoma of the head and neck, and breast cancer.

The company said this trial brings us one step closer to a new treatment option for underserved cancer patients as there is no specific treatment currently approved for the treatment of skin toxicities associated with EGFRi therapies.

The company added it will advance HT-001 into the clinical phase as it is a key treatment in the onco-dermatology space and anticipates beginning the Phase 2a trial in the first quarter of 2023.

read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews | Před 714 dny
CAC 40 Down Nearly 0.6% In Cautious Trade

CAC 40 Down Nearly 0.6% In Cautious Trade

French stocks remain in negative territory on Monday, with investors mostly making cautious moves, looking for some more clarity on U.S. - EU trade deal, and awaiting crucial inflation data from the region.
RTTNews | Před 15 minutami
DAX Modestly Lower As Investors Wait For Directional Clues

DAX Modestly Lower As Investors Wait For Directional Clues

The German market is languishing in negative territory after a weak start on Monday as investors remain a bit reluctant to pick up stocks, choosing to wait for crucial inflation data from several major countries in Europe.
RTTNews | Před 48 minutami
Antipodean Currencies Traded Higher Amid Risk-on Mood

Antipodean Currencies Traded Higher Amid Risk-on Mood

The antipodean currencies such as the Australia and New Zealand dollars strengthened against their major currencies in the Asian session on Monday, as Asian stock markets traded higher, on an improved outlook for interest rates after US Fed Chair Jerome Powell's dovish comments at the conference in Jackson Hole on Friday. Powell said economic risks are 'shifting' and a rate cut may be warranted.
RTTNews | Před 1 h 32 min